Sozen, MM; Whittall, R; Oner, C; Tokatli, AE; Kalkanoglu, HS; Dursun, A; ... Humphries, SE; + view all Sozen, MM; Whittall, R; Oner, C; Tokatli, AE; Kalkanoglu, HS; Dursun, A; Coskun, T; Oner, R; Humphries, SE; - view fewer (2005) The molecular basis of familial hypercholesterolaemia in Turkish patients. ATHEROSCLEROSIS , 180 (1) 63 - 71. 10.1016/j.athersclerosis.2004.12.042.
Full text not available from this repository.
Familial hypercholesterolaemia (FH) is an autosomal dominant disorder of lipoprotein metabolism. In the majority of patients FH is caused by mutations in the gene for the low-density lipoprotein receptor (LDLR), and to date more than 700 mutations have been reported worldwide. In this study,. 36 paediatric patients with a clinical diagnosis of FH (20 homozygous and 16 heterozygotes) were screened for mutations in the LDLR gene. Each exon, with intron-exon junctions, was screened by capillary fluorescent SSCP (F-SSCP) and heteroduplex analysis. Samples showing different band patterns were sequenced. Ten novel (including three frame shift small deletions or insertions) and seven known mutations were detected. A total of 37 out of the predicted 56 FH-causing alleles were identified (66.1%). No patients with the R3500Q mutation in the APOB gene were found. W556R was the most common mutation, explaining 21.4% of the predicted defective LDLR alleles. The novel sequence changes were deemed to be pathogenic if they altered a conserved amino acid (L143P, D147E, Q233H-C234G, C347G) or occurred in or close to a splice site (IVS 16 + 5) and were absent in DNA from 50 healthy Turkish subjects. These data confirm the genetic heterogeneity of FH in Turkey, and demonstrate the usefulness of F-SSCP for mutation detection. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
|Title:||The molecular basis of familial hypercholesterolaemia in Turkish patients|
|Keywords:||familial hypercholesterolaemia, FH, LDLR, SSCP, Turkish, mutation screening, LDL-RECEPTOR GENE, APOLIPOPROTEIN-B, UNITED-KINGDOM, MUTATION, IDENTIFICATION, MANAGEMENT, SPECTRUM, LOCUS|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record